Table 3.
Rank of health care providers and practices relating to sickle cell screening
| Patients given option to do sickling test | OR (95% CI) | P-value | ||
|---|---|---|---|---|
| Yes: N = 20 | No: N = 82 | |||
| Role | ||||
| Consultant | 3 (15) | 11 (13.4) | 1.14 (0.29–4.54) | 1.000 |
| Resident/HO | 8 (40.0) | 27 (32.9) | 1.36 (0.50–3.71) | 0.604 |
| Nurse/midwife | 9 (45.0) | 44 (53.7) | 0.71 (0.26–1.89) | 0.619 |
| Patients told their carrier status | ||||
|---|---|---|---|---|
| Variable | Yes: N = 65 | No: N = 37 | ||
| Role | ||||
| Consultant | 12 (18.5) | 2 (5.4) | 3.96 (0.84–18.79) | 0.078 |
| Resident/HO | 27 (41.5) | 8 (21.6) | 2.58 (1.02–6.50) | 0.052 |
| Nurse/midwife | 26 (40.0) | 27 (73.0) | 0.25 (0.10–0.59) | 0.002 |
| Receipt of results by patients who do not have SCT (i.e., AA) | ||||
|---|---|---|---|---|
| Yes: N = 97 | No: N = 5 | |||
| Role | ||||
| Consultant | 14 (14.4) | 0 (0.0) | – | 1.000 |
| Resident/HO | 33 (34.0) | 2 (40.0) | 0.77 (0.12–4.86) | 1.000 |
| Nurse/midwife | 50 (51.5) | 3 (60.0) | 0.71 (0.11–4.43) | 1.000 |
| Communication of genotype status to patients who do not have the SCT (i.e., AA) | ||||
|---|---|---|---|---|
| Yes: N = 64 | No: N = 38 | |||
| Role | ||||
| Consultant | 11 (17.2) | 3 (7.9) | 2.42 (0.63–9.30) | 0.242 |
| Resident/HO | 19 (29.7) | 16 (42.1) | 0.58 (0.25–1.34) | 0.281 |
| Nurse/midwife | 34 (53.1) | 19 (50.0) | 1.13 (0.51–2.53) | 0.839 |
N = number; OR = odds ratio; SCT = sickle cell trait.